NUP88 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.782600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.997400E-01
Normal-vs-Stage2
3.602800E-01
Normal-vs-Stage3
9.558200E-02
Normal-vs-Stage4
3.507600E-01
Stage1-vs-Stage2
4.512000E-01
Stage1-vs-Stage3
1.020240E-01
Stage1-vs-Stage4
5.451000E-01
Stage2-vs-Stage3
8.401900E-02
Stage2-vs-Stage4
8.883400E-01
Stage3-vs-Stage4
1.365560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.762800E-01
Normal-vs-AfricanAmerican
5.210600E-01
Normal-vs-Asian
1.407360E-01
Caucasian-vs-AfricanAmerican
2.949000E-01
Caucasian-vs-Asian
8.353000E-01
AfricanAmerican-vs-Asian
3.719000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.594800E-01
Normal-vs-Female
4.020800E-01
Male-vs-Female
3.055000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.480600E-01
Normal-vs-Age(41-60Yrs)
4.625600E-01
Normal-vs-Age(61-80Yrs)
3.380000E-01
Normal-vs-Age(81-100Yrs)
3.993600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.715600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.618600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.424000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.318100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.652000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.885000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.788200E-02
Normal-vs-Daily Drinker
3.021800E-01
Normal-vs-Weekly Drinker
3.264800E-01
Normal-vs-Occasional Drinker
4.568200E-01
Normal-vs-Social Drinker
3.925200E-01
Non Drinker-vs-Daily Drinker
3.055000E-01
Non Drinker-vs-Weekly Drinker
5.667200E-01
Non Drinker-vs-Occasional Drinker
3.949800E-01
Non Drinker-vs-Social Drinker
8.513400E-01
Daily Drinker-vs-Weekly Drinker
7.546000E-01
Daily Drinker-vs-Occasional Drinker
4.310500E-02
Daily Drinker-vs-Social Drinker
2.039800E-01
Weekly Drinker-vs-Occasional Drinker
1.578820E-01
Weekly Drinker-vs-Social Drinker
4.316800E-01
Occasional Drinker-vs-Social Drinker
5.021200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.251200E-01
Normal-vs-Grade 2
9.638400E-01
Normal-vs-Grade 3
9.827200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.399030E-01
Grade 1-vs-Grade 3
9.532200E-02
Grade 1-vs-Grade 4
6.251200E-01
Grade 2-vs-Grade 3
6.931600E-01
Grade 2-vs-Grade 4
9.638400E-01
Grade 3-vs-Grade 4
9.827200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.375800E-01
Normal-vs-NonDiabetic
3.765000E-01
Diabetic-vs-NonDiabetic
3.566000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.190430E-01
Normal-vs-NoPancreatitis
3.675800E-01
Pancreatitis-vs-NoPancreatitis
7.974800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.458220E-01
Normal-vs-N1
3.448200E-01
N0-vs-N1
4.163500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.030800E-01
Normal-vs-TP53-NonMutant
2.543600E-01
TP53-Mutant-vs-TP53-NonMutant
6.05229999999235E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
